
    
      A Prospective, Multi-Center, Open Label, Randomized Controlled, two-arm Study to Evaluate the
      Safety and Efficacy of the Permanent Polymer Zotarolimus Eluting Stent 'Resolute Integrity™'
      Compared to Polymer Free Amphilimus Eluting Stent 'Cre8'. Dual Antiplatelet Therapy duration
      of 1 Month will be applied in stable angina pectoris patient population. Myocardial
      infarction patient population will be treated with 12 months of dual antiplatelet therapy
      (DAPT).

      One thousand five hundred thirty-two (1532) patients (1:1 randomization Cre8 stent: Resolute
      Integrity™ stent) will be enrolled in the study, with clinical follow-up at 12 months to
      assess the primary end point.

      After a period of 12 months, a clinical registry will be implemented Information will be
      collected at 3-years post procedure.
    
  